Medical Journals

Structure-selectivity Investigations of D2-like Receptor Ligands by Comfa and Comsia Guiding the Discovery of D3 Selective Pet Radioligands.

Authors:
  • Salama Ismail
  • Hocke Carsten
  • Utz Wolfgang
  • Prante Olaf
  • Boeckler Frank
  • Hübner Harald
  • Kuwert Torsten
  • Gmeiner Peter

From: Department of Medicinal Chemistry, Emil Fischer Center, Friedrich Alexander University, Schuhstrasse 19, D-91052 Erlangen, Germany.

Journal of medicinal chemistry

  • Publish Date: Feb 2007
  • ISSN: 0022-2623
  • Volume: 50
  • Issue: 3
  • Pages: 489-500
  • Medium: Print
  • Language: English
  • Citation (JAMA): Salama Ismail, Hocke Carsten, Utz Wolfgang, et al. Structure-selectivity Investigations of D2-like Receptor Ligands by Comfa and Comsia Guiding the Discovery of D3 Selective Pet Radioligands.. J. Med. Chem. Feb 2007;50:489-500

Abstract

Elucidation of the physiological role of the D3 receptor and its distribution in the brain using positron emission tomography (PET) is hampered by the lack of bioavailable subtype selective tracer ligands. To develop appropriate D3 radioligands, we designed an integrative procedure involving the elucidation of structural features determining D3 selectivity over both congeners D2 and D4 by comparative molecular analysis. Thus, we have successfully generated CoMFA and CoMSIA models based on the affinitiy differences of a series of 79 ligands representing a broad range of selectivities. These models yielded highly significant cross-validations (q2cv(D3/D2) = 0.86; q2cv(D3/D4) = 0.92) and excellent predictions of a 16-ligand test set (r2pred = 0.79-0.93). Exploiting this information, synthesis and receptor binding studies directed us to the fluorinated lead compounds 78 and 79, featuring subnanomolar D3 affinities and considerable selectivities over D2 and D4 and, subsequently, to the subtype selective PET tracers [18F]78 and [18F]79.

Mesh Headings (Keywords): Animals, Benzamides, Fluorine Radioisotopes, Ligands, Models, Molecular, Molecular Conformation, Piperazines, Positron-Emission Tomography, Quantitative Structure-Activity Relationship, Radioligand Assay, Radiopharmaceuticals, Receptors, Dopamine D2, Receptors, Dopamine D3, Swine


Check for Full Text / PubMed Unique Identifier (PMID): 17266201


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.